Laing O’Rourke has secured the contract to deliver phase 1a of Oxford North’s £700 million new innovation district comprising the Red Hall and the first two laboratory buildings.
Brainomix, an Oxford-based leading AI-powered medtech solutions company, is expanding its presence in the US with the introduction of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care.
Oxford City Council has given the green light for the development of a distinctive timber cycle pavilion in the central area of Oxford North that will offer secure long-stay and short-stay cycling spaces.
Moa Technology, the agricultural biotechnology company tackling herbicide-resistant weeds that threaten the world’s food security, has announced the appointment of Rob Quinn as Chief Financial Officer (CFO) and Apostolos Klontzaris as Chief Business Officer (CBO)
A historic ‘Milton Wonder’ sapling has been planted by the Lord Lieutenant of Oxfordshire to commemorate His Majesty’s Coronation on the day of his 75th birthday.
Work is set to begin on a new entrance and relocated Pioneer Memorial as part of the wider road and access improvement programme at the Graven Hill development near Bicester.
OMass Therapeutics, a biotechnology company at ARC Oxford identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, has announced the appointment of Melissa Faris as Chief Business Officer.
Oxford Nanopore and Day Zero Diagnostics have announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
Parkwalk Advisors, the UK’s most active investor in university spinouts, has launched its third Knowledge Intensive EIS Fund, which will invest in science and deep tech businesses from UK universities.